Stay updated on ALKS 4230 and Pembrolizumab in Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the ALKS 4230 and Pembrolizumab in Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ALKS 4230 and Pembrolizumab in Head and Neck Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The record history now includes a new revision entry (v3.6.4), indicating a page version update. This change affects only the page's metadata and does not modify the study data, conditions, or listings.
    Difference
    0.1%
    Check dated 2026-07-28T04:59:10.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    A new revision entry v3.6.3 was added to the study record history, and the previous entry v3.6.2 was removed from the list.
    Difference
    0.1%
    Check dated 2026-07-06T18:19:09.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    A new revision entry v3.6.2 was added to the study record history, and the previous revision v3.6.0 was removed.
    Difference
    0.1%
    Check dated 2026-06-29T15:51:31.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    A new study version v3.6.0 was posted with a recruitment-status update indicating no longer looking for participants, and the previous version v3.5.5 was removed from the history.
    Difference
    0.4%
    Check dated 2026-06-15T08:42:34.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The record history now shows the latest revision as v3.5.5, replacing the previous v3.5.4 entry in the changes list.
    Difference
    0.1%
    Check dated 2026-06-08T04:24:54.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    An additional revision entry, v3.5.4, was added to the Study Record History, extending the version history after v3.5.3. The previous revision v3.5.3 has been removed from the current change set.
    Difference
    0.1%
    Check dated 2026-05-18T03:27:13.000Z thumbnail image

Stay in the know with updates to ALKS 4230 and Pembrolizumab in Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ALKS 4230 and Pembrolizumab in Head and Neck Cancer Clinical Trial page.